Veronica V. Rezelj - Concepedia

Author

Veronica V. Rezelj

Institut Pasteur ORCID

Also Known As

Rezelj, Veronica Valentina, Sali, Andrej, V. Rezelj, Veronica Rezelj, Veronica V Rezelj, Veronica V. Rezelj

Publications

8.4K

Citations

H-Index

Concepts

All Affiliations

Institut Pasteur Centre National de la Recherche Scientifique University of California, San Francisco Icahn School of Medicine at Mount Sinai Howard Hughes Medical Institute

About

Veronica V. Rezelj is an author at Institut Pasteur specializing in virology, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	2.2K
2	Engineering	1	1	462
3	Biomedical Engineering	1	1	462
4	Biostatistics	1	1	14
5	Epidemiology	1	1	49

Veronica V. Rezelj

Publications

8.3K

Citations

H-Index

Page 1

	Year	Citations
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing David E. Gordon, Gwendolyn Μ. Jang, Mehdi Bouhaddou, Nature	2020	4.8K
The Global Phosphorylation Landscape of SARS-CoV-2 Infection Mehdi Bouhaddou, Danish Memon, Bjoern Meyer, Cell Global Phosphorylation LandscapeViral PathogenesisVirologyViral Structural ProteinMedicine	2020	1.1K
Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms David E. Gordon, Joseph Hiatt, Mehdi Bouhaddou, Science Viral DiagnosticsCovid-19 PandemicViral PathogenesisImmunologyMolecular Biology	2020	794
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike Michael Schoof, Bryan Faust, Reuben A. Saunders, Science Materials ScienceTrivalent NanobodySpike ProteinEngineeringNanotechnology	2020	462
Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, Brazil Claire L. Donald, Benjamin Brennan, Stephanie L. Cumberworth, PLoS neglected tropical diseases	2016	241
Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2 Tia A. Tummino, Veronica V. Rezelj, Benoit Fischer, Science Medicinal ChemistryAntiviral ActivityMedicineImmunologyEarly Drug Discovery	2021	218
Host PDZ‐containing proteins targeted by SARS‐CoV‐2 Célia Caillet‐Saguy, Fabien Durbesson, Veronica V. Rezelj, FEBS Journal	2021	72
Defective viral genomes as therapeutic interfering particles against flavivirus infection in mammalian and mosquito hosts Veronica V. Rezelj, Lucía Carrau, Fernando Merwaiss, Nature Communications	2021	67
Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20 Junjie Feng, Arthur Wickenhagen, Matthew L. Turnbull, Journal of Virology	2018	58
Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets Kelsey M. Haas, Michael McGregor, Mehdi Bouhaddou, Nature Communications	2023	51

Page 1